Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002

Fabrizio Schifano, John Corkery, Eilish Gilvarry, Paolo Deluca, Adenekan Oyefeso, A. Hamid Ghodse

    Research output: Contribution to journalArticlepeer-review

    31 Citations (Scopus)


    Buprenorphine safety in overdose has been debated recently, but no mortality data related to this compound from the UK have been published. To gather together all of the buprenorphine mortality figures, a number of different sources have been checked. To inform on buprenorphine safety issues, accessible information related to its availability indicators (i.e. prescriptions; seizures) data for the 1980-2002 time frame have been sought. In the UK, during this period, buprenorphine was mentioned in 43 fatalities. Typically, victims were males in the 25-44 age group. In 12 cases (28% of total), a verdict of suicide was given. Buprenorphine was detected on its own in seven cases; more frequently, it was found together with benzodiazepines and other opiates. Large quantities of buprenorphine were prescribed both in England in 1985-1989 and in 1991-1992 in Scotland, where seizures reached their highest levels. Buprenorphine prescriptions seemed to peak again after 1999, when high dose buprenorphine formulations entered the UK market. No positive correlation was found between the number of buprenorphine deaths over the years and either buprenorphine dispensings/prescriptions or seizures. However, an increase in buprenorphine-related deaths since 1999 was identified and this may be an issue which should be carefully monitored over the next few years.
    Original languageEnglish
    Pages (from-to)343-8
    Number of pages6
    JournalHuman Psychopharmacology: Clinical and Experimental
    Issue number5
    Publication statusPublished - 2005


    • Adult
    • Aged
    • Buprenorphine
    • Drug Utilization
    • Female
    • Great Britain
    • Humans
    • Male
    • Middle Aged
    • Mortality
    • Overdose
    • Seizures
    • Time Factors


    Dive into the research topics of 'Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002'. Together they form a unique fingerprint.

    Cite this